Menu utilisateur

Accès à distance ? S'identifier sur le proxy UCLouvain

Rechercher

Affichage: 5 résultats.
    • Article de périodique
    ABVD (8 cycles) versus BEACOPP (4 escalated cycles ≥4 baseline): Final results in stage III-IV low-risk Hodgkin lymphoma (IPS 0-2) of the LYSA H34 randomized trial
    Mounier, N. Brice, P. Bologna, S. Briere, J. Gaillard, I. Heczko, M. Gabarre, J. Casasnovas, O. Jaubert, J. Colin, P. Delmer, A. Devidas, A. Bachy, E. Nicolas-Virelizier, E. Aoudjhane, A. Humbrecht, C. André, M.[UCL] Carde, P. Divine, M. Fenaux, P. Coiffier, B. Reman, O. Aoudjhane, M. Blaise, A.M. Bordessoule, D. Bosly, André[UCL] Morschhauser, F. Caillot, D. Gonzalez, H. Lederlin, P. Bouabdallah, R. van Hoof, A. Boulat, O. Bauduer, F. Tournilhac, O. Decaudin, D. Sebban, C. Janvier, M. Kentos, A. Voillat, L. Fabbro, M. Eisenmann, J.C. Martin, C. Christian, B. Ferrant, Augustin[UCL] Salanoubat, C. Varet, B. Bouabdallah, K. de Prijck, B. Levaltier, X. Castaigne, S. Audhuy, B. Frenkiel, N. Rose, C. Fitoussi, O. Orfeuvre, H. Pignon, J.M. (2014) Annals of Oncology — Vol. 25, no.8, p. 1622-1628 (2014)
    • Article de périodique
    Intravenous itraconazole followed by oral itraconazole in the treatment of invasive pulmonary aspergillosis in patients with hematologic malignancies, chronic granulomatous disease, or AIDS
    Caillot, D. Bassaris, H McGeer, A Arthur, C Prentice, HG. Seifert, W De Beule, K (2001) Clinical Infectious Diseases — Vol. 33, no. 8, p. E83-E90 (2001)
    • Communication
    Bortezomib Plus Dexamethasone Versus Reduced-dose Bortezomib Plus Thalidomide-dexamethasone As Induction Prior To Autologous Transplantation in Newly Diagnosed Myeloma
    Harousseau, J. L. Avet-Loiseau, H. Mary, J. Facon, T. Attal, M. Doyen, Chantal[UCL] Hulin, C. Garderet, L. Tiab, M. Lepeu, G. Araujo, C. Caillot, D. Petillon, M. Mathiot, C. Moreau, P. (2010) 15th Annual Meeting of the European-Hematology-Association — Barcelona(Spain)
    • Article de périodique
    Comparison of chemotherapy to radiotherapy as consolidation of complete or good partial response after six cycles of chemotherapy for patients with advanced Hodgkin's disease: results of the Groupe d'etudes des Lymphomes de l'Adulte H89 trial
    Ferme, C Ferrant, Augustin[UCL] Sebban, C. Hennequin, C Divine, M. Lederlin, P. Gabarre, J Caillot, D. Bordessoule, D. Brice, P. Moullet, I Berger, F. Lepage, E. (2000) Blood — Vol. 95, no. 7, p. 2246-2252 (2000)
    • Article de périodique
    Heterogeneity of t(4;14) in multiple myeloma. Long-term follow-up of 100 cases treated with tandem transplantation in IFM99 trials
    Moreau, P. Attal, M. Garban, F. Hulin, C. Facon, T. Marit, G. Michallet, M. Doyen, Chantal[UCL] Leyvraz, S. Mohty, M. Wetterwald, M. Mathiot, C. Caillot, D. Berthou, C. Benboubker, L. Garderet, L. Chaleteix, C. Traullé, C. Fuzibet, J. G. Jaubert, J. Lamy, T. Casassus, P. Dib, M. Kolb, B. Dorvaux, V. Grosbois, B. Yakoub-Agha, I. Harousseau, J. L. Avet-Loiseau, H. SAKK IFM Group (2007) Leukemia — Vol. 21, no.9, p. 2020-2024 (2007)